COVID-19 Variant Supplement – Neutralizing human-derived single-chain antibodies against SARS-CoV-2 Bach, Horacio | University of British Columbia | Operating Grant | $50,000 CIHR British Columbia 2021 Read More
Repurposing an FDA-approved anti-gout drug for the treatment of COVID-19 Luo, Honglin | University of British Columbia | Project Grant | $562,275 CIHR British Columbia 2021 Read More
COVID-19 Variant Supplement – Protecting healthcare workers from COVID-19: A comparative contextualized analysis Yassi, Annalee | University of British Columbia | Operating Grant | $49,626 CIHR British Columbia 2021 Read More